Preliminary Study on the Relationship of BRAF Mutations with the Outcome of the First 131I Radiotherapy and Malignant Biological Characteristics in Papillary Thyroid Carcinoma
Linjue Shangguan,1,* Peipei Zhang,1 Shengwei Fang,1 Kaili Xiang,1 Yawen Geng,1 Dingcun Luo,2,* Chunlei Zhao1,* 1Department of Nuclear Medicine, Hangzhou Cancer Hospital, Hangzhou, 310002, People’s Republic of China; 2Department of Tumor Surgery, Hangzhou First People’s Hospit...
Guardado en:
Autores principales: | Shangguan L, Zhang P, Fang S, Xiang K, Geng Y, Luo D, Zhao C |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/379fb3b185544333a7006f17d5d8036a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
BRAF V600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm
por: Jennifer A. Silver, et al.
Publicado: (2021) -
Mutation in Genes Encoding Key Functional Groups Additively Increase Mortality in Patients with <i>BRAF<sup>V600E</sup></i>-Mutant Advanced Papillary Thyroid Carcinoma
por: Eyun Song, et al.
Publicado: (2021) -
A case report of simultaneous medullary and papillary carcinoma of thyroid
por: Ziaolhagh Reza, et al.
Publicado: (2021) -
Clinicopathological Significance of BRAF (V600E), NRAS (Q61K) and TERT (C228T, C250T and SNP Rs2853669) Mutations in Bulgarian Papillary Thyroid Carcinoma Patients
por: Vidinov K., et al.
Publicado: (2021) -
Impact of Multifocality on the Recurrence of Papillary Thyroid Carcinoma
por: Joohyun Woo, et al.
Publicado: (2021)